Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Cesium carbonate | HCID 10796 | — |
| Reactant | 1-Acetylpiperazine | HCID 83795 | — |
| Reactant | HCID 90409510 | HCID 90409510 | — |
| Catalyst | Bis(dibenzylideneacetone)palladium | HCID 9811564 | — |
| Solvent | 1,4-Dioxane | HCID 31275 | — |
| Product | HCID 85470480 | HCID 85470480 | 31% |
Reaction Steps
A mixture of 2-[(4-bromo-2-fluorophenyl)methyl]-7-phenyl-1λ6,2,7-thiadiazepane-1,1-dione (200 mg, 0.48 mmol), 1-(piperazin-1-yl)ethanone (93 mg, 0.72 mmol), Pd2(dba)3 (44 mg, 0.048 mmol), Xant-phos (55 mg, 0.096 mmol), and Cs2CO3 (469 mg, 1.44 mmol) in 1,4-dioxane (10 mL) under nitrogen atmosphere was stirred at 100° C. for 16 hours. The reaction mixture was filtered and concentrated under reduced pressure. The crude product was purified by preparative HPLC to afford 2-{[4-(4-Acetylpiperazin-1-yl)-2-fluorophenyl]methyl}-7-phenyl-1λ6,2,7-thiadiaze-pane-1,1-dione as brown oil (68 mg, 31%). 1H NMR (500 MHz, CDCl3) δ ppm 7.35-7.40 (m, 6H), 6.67-6.69 (m, 1H), 6.55-6.58 (m, 1H), 4.50 (s, 2H), 3.76 (t, J=5.5, 2H), 3.60-3.65 (m, 4H), 3.36 (t, J=5.5, 2H), 3.16-3.21 (m, 4H), 2.14 (s, 3H), 1.98 (t, J=5, 2H), 1.90 (t, J=3.5, 2H); LCMS (ESI): m/z=234.9 [M-2-phenyl-1λ6,2,7-thiadiazepane-1,1-dione+H]+.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08912219B2 |
|---|
| Source dataset | uspto-grants-2014_12 |
|---|
| ORD ID | ord-5df40ac49cf84760868e0caf4f7f1891 |
|---|
| Source note | uspto-grants-2014_12 |
|---|